Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

1S19

Crystal structure of VDR ligand binding domain complexed to calcipotriol.

Summary for 1S19
Entry DOI10.2210/pdb1s19/pdb
Related1DB1 1IE8 1IE9 1S0Z
DescriptorVitamin D3 receptor, CALCIPOTRIOL (3 entities in total)
Functional Keywordsnuclear receptor, transcription regulation, alpha-helical sandwich, gene regulation
Biological sourceHomo sapiens (human)
More
Cellular locationNucleus: P11473
Total number of polymer chains1
Total formula weight30217.95
Authors
Tocchini-Valentini, G.,Rochel, N.,Wurtz, J.M.,Moras, D. (deposition date: 2004-01-06, release date: 2004-04-13, Last modification date: 2024-02-14)
Primary citationTocchini-Valentini, G.,Rochel, N.,Wurtz, J.M.,Moras, D.
Crystal structures of the vitamin D nuclear receptor liganded with the vitamin D side chain analogues calcipotriol and seocalcitol, receptor agonists of clinical importance. Insights into a structural basis for the switching of calcipotriol to a receptor antagonist by further side chain modification.
J.Med.Chem., 47:1956-1961, 2004
Cited by
PubMed Abstract: The plethora of actions of 1alpha,25(OH)(2)D(3) in various systems suggested wide clinical applications of vitamin D nuclear receptor (VDR) ligands in treatments of inflammation, dermatological indication, osteoporosis, cancers, and autoimmune diseases. More than 3000 vitamin D analogues have been synthesized in order to reduce the calcemic side effects while maintaining the transactivation potency of these ligands. Here, we report the crystal structures of VDR ligand binding domain bound to two vitamin D agonists of therapeutical interest, calcipotriol and seocalcitol, which are characterized by their side chain modifications. These structures show the conservation of the VDR structure and the adaptation of the side chain anchored by hydroxyl moieties. The structure of VDR-calcipotriol helps us to understand the structural basis for for the switching of calcipotriol to a receptor antagonist by further side chain modification. The VDR-seocalcitol structure, in comparison with the structure of VDR-KH1060, a superagonist ligand closely related to seocalcitol, shows adaptation of the D ring and position of C-21 in order to adapt its more rigid side chain.
PubMed: 15055995
DOI: 10.1021/jm0310582
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.1 Å)
Structure validation

227111

건을2024-11-06부터공개중

PDB statisticsPDBj update infoContact PDBjnumon